WallStreetZenWallStreetZen

NASDAQ: HRMY
Harmony Biosciences Holdings Inc Stock

$34.71+0.70 (+2.06%)
Updated Jul 16, 2024
HRMY Price
$34.71
Fair Value Price
N/A
Market Cap
$1.97B
52 Week Low
$18.61
52 Week High
$39.27
P/E
14.77x
P/B
3.82x
P/S
3.09x
PEG
0.63x
Dividend Yield
N/A
Revenue
$617.51M
Earnings
$137.70M
Gross Margin
79.3%
Operating Margin
34.5%
Profit Margin
22.3%
Debt to Equity
0.64
Operating Cash Flow
$208M
Beta
0.9
Next Earnings
Jul 30, 2024
Ex-Dividend
N/A
Next Dividend
N/A

HRMY Overview

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how HRMY scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

HRMY ($34.71) is trading above its intrinsic value of $32.09, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
HRMY is good value based on its earnings relative to its share price (14.77x), compared to the US market average (31.71x)
P/E vs Market Valuation
HRMY is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more HRMY due diligence checks available for Premium users.

Be the first to know about important HRMY news, forecast changes, insider trades & much more!

HRMY News

Valuation

HRMY price to earnings (PE)

For valuing profitable companies with steady earnings
Company
14.77x
Industry
-18x
Market
31.71x
HRMY is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
HRMY is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

HRMY price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
3.82x
Industry
6.51x
HRMY is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

HRMY price to earnings growth (PEG)

For valuing profitable companies with growth potential
HRMY is good value based... subscribe to Premium to read more.
PEG Value Valuation

HRMY's financial health

Profit margin

Revenue
$154.6M
Net Income
$38.3M
Profit Margin
24.8%
HRMY's Earnings (EBIT) of $213.05M... subscribe to Premium to read more.
Interest Coverage Financials
HRMY's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$847.0M
Liabilities
$331.6M
Debt to equity
0.64
HRMY's short-term assets ($479.50M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
HRMY's short-term assets ($479.50M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
HRMY's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$31.1M
Investing
-$6.2M
Financing
-$3.6M
HRMY's operating cash flow ($207.97M)... subscribe to Premium to read more.
Debt Coverage Financials

HRMY vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
HRMY$1.97B+2.06%14.77x3.82x
VCYT$1.95B+13.15%-27.48x1.75x
CPRX$2.01B+1.43%28.32x3.57x
AKRO$1.92B+0.91%-8.58x2.26x
VERA$2.04B+1.33%-18.17x5.76x

Harmony Biosciences Holdings Stock FAQ

What is Harmony Biosciences Holdings's quote symbol?

(NASDAQ: HRMY) Harmony Biosciences Holdings trades on the NASDAQ under the ticker symbol HRMY. Harmony Biosciences Holdings stock quotes can also be displayed as NASDAQ: HRMY.

If you're new to stock investing, here's how to buy Harmony Biosciences Holdings stock.

What is the 52 week high and low for Harmony Biosciences Holdings (NASDAQ: HRMY)?

(NASDAQ: HRMY) Harmony Biosciences Holdings's 52-week high was $39.27, and its 52-week low was $18.61. It is currently -11.6% from its 52-week high and 86.5% from its 52-week low.

How much is Harmony Biosciences Holdings stock worth today?

(NASDAQ: HRMY) Harmony Biosciences Holdings currently has 56,791,861 outstanding shares. With Harmony Biosciences Holdings stock trading at $34.71 per share, the total value of Harmony Biosciences Holdings stock (market capitalization) is $1.97B.

Harmony Biosciences Holdings stock was originally listed at a price of $37.01 in Aug 19, 2020. If you had invested in Harmony Biosciences Holdings stock at $37.01, your return over the last 3 years would have been -6.21%, for an annualized return of -2.12% (not including any dividends or dividend reinvestments).

How much is Harmony Biosciences Holdings's stock price per share?

(NASDAQ: HRMY) Harmony Biosciences Holdings stock price per share is $34.71 today (as of Jul 16, 2024).

What is Harmony Biosciences Holdings's Market Cap?

(NASDAQ: HRMY) Harmony Biosciences Holdings's market cap is $1.97B, as of Jul 18, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Harmony Biosciences Holdings's market cap is calculated by multiplying HRMY's current stock price of $34.71 by HRMY's total outstanding shares of 56,791,861.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.